The Optimal Use of Imaging in Radiation Therapy for Lymphoma: Guidelines from the International Lymphoma Radiation Oncology Group (ILROG)-Reference-Cited by-同舟云学术

The Optimal Use of Imaging in Radiation Therapy for Lymphoma: Guidelines from the International Lymphoma Radiation Oncology Group (ILROG)

Published:2019-07 Issue:3 Volume:104 Page:501-512
ISSN:0360-3016
Container-title:International Journal of Radiation Oncology*Biology*Physics
language:en
Short-container-title:International Journal of Radiation Oncology*Biology*Physics

Author:

Mikhaeel N. George,Milgrom Sarah A.,Terezakis Stephanie,Berthelsen Anne Kiil,Hodgson David,Eich Hans Theodor,Dieckmann Karin,Qi Shu-nan,Yahalom Joachim,Specht Lena

Publisher

Elsevier BV

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology,Radiation

Reference61 articles.

1. Role of imaging in the staging and response assessment of lymphoma: Consensus of the International Conference on Malignant Lymphomas Imaging Working Group;Barrington;J Clin Oncol,2014

2. Recommendations for initial evaluation, staging, and response assessment of Hodgkin and non-Hodgkin lymphoma: The Lugano classification;Cheson;J Clin Oncol,2014

3. 18)F-FDG avidity in lymphoma readdressed: A study of 766 patients;Weiler-Sagie;J Nucl Med,2010

4. When should FDG-PET be used in the modern management of lymphoma?;Barrington;Br J Haematol,2014

5. Long-term course of patients with stage IA nodular lymphocyte-predominant Hodgkin lymphoma: A report From the German Hodgkin Study Group;Eichenauer;J Clin Oncol,2015

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evolution, and current and future role of radiotherapy in the treatment of haematological malignancies;The Lancet Haematology;2024-07

2. Knowledge and competences in hematological malignancies amongst radiation oncology residents in Germany—results from a national survey;Strahlentherapie und Onkologie;2024-04-29

3. Evolution of Radiation Fields from Involved Field to Involved Site—A Summary of the Current Guidelines by the International Lymphoma Radiation Oncology Group;Lymphatics;2023-11-08

4. Development and validation of CT‑based radiomics model of PET-negative residual CT masses: a potential biomarker for predicting relapse‑free survival in non-Hodgkin lymphoma patients showing complete metabolic response;Abdominal Radiology;2023-10-27

5. In Regard to Campbell et al.;International Journal of Radiation Oncology*Biology*Physics;2023-06